Home LiteratureArticle Details
PMID: 879751 Published · ppublish English Journal Article

Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B.

Antimicrobial agents and chemotherapy ·Vol. 11 ·No. 6 ·1977-06-00 ·Pages 1049-55

Collins MS, Pappagianis D

Abstract

The susceptibility of 12 strains of Coccidioides immitis to amphotericin B (amB) was studied in vitro and in vivo. The minimal inhibitory concentration (MIC) of the mycelial phase of these strains was 0.078 to 0.16 mug/ml after 3 days of incubation, but by 15 days all strains were inhibited by 2.5 mug/ml. Mice infected intraperitoneally with these strains were sucessfully treated with 0.5 mg of amB per kg per day. These strains included several studied by others and which reportedly varied widely in susceptibility (MIC from 0.24 to 24.01 mug/ml) to amB. Four of these strains representing this putative broad range of susceptibility were used to infect mice intranasally. Regardless of infecting strain, mice were sucessfully treated with 0.38, 0.75, and 1.5 mg/kg, but 0.19 mg/kg was only partially effective. Thus, in vivo as well as in vitro there was a uniform response of C. immitis strains to amB.

MeSH Terms
Amphotericin B/blood,pharmacology Animals Coccidioides/drug effects Coccidioidomycosis/blood,drug therapy Female Mice Species Specificity
Chemicals
Amphotericin B
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Collins M S
Pappagianis D
References (25)
25 references, click to expand
  1. The use of amphotericin B in the treatment of coccidioidal disease.
    Am J Med. 1959 Oct;27:617-35 PMID: 13845276
  2. Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy.
    Am J Med. 1968 Sep;45(3):405-18 PMID: 5672740
  3. A therapeutic dilemma. The treatment of disseminated coccidioidomycosis with amphotericin B.
    Ann Intern Med. 1962 Apr;56:553-63 PMID: 14496918
  4. Experience with amphotericin B.
    Ann N Y Acad Sci. 1960 Aug 27;89:202-20 PMID: 13749466
  5. Immunization of mice with viable Cocidioides immitis.
    J Immunol. 1961 Jan;86:28-34 PMID: 13732668
  6. Approaches to the physiology of Coccidioides immitis.
    Ann N Y Acad Sci. 1960 Aug 27;89:109-21 PMID: 13732667
  7. Experience with amphotericin B for the treatment of systemic mycoses.
    AMA Arch Intern Med. 1958 Dec;102(6):960-76 PMID: 13593903
  8. The determination of serum concentrations of amphotericin B in man.
    Am Rev Tuberc. 1958 Jun;77(6):1023-5 PMID: 13533822
  9. Coccidioidomycosis and its treatment with amphotericin B.
    Am J Med. 1958 Apr;24(4):568-92 PMID: 13520758
  10. Some aspects of the absorption, distribution, and excretion of amphotericin B in man.
    Antibiotic Med Clin Ther (New York). 1958 May;5(5):295-301 PMID: 13521767
  11. An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man.
    J Invest Dermatol. 1957 Mar;28(3):217-31; discussion, 231-2 PMID: 13429161
  12. Relationship of the in vivo form of Coccidioides immitis to virulence.
    J Infect Dis. 1956 May-Jun;98(3):312-9 PMID: 13346127
  13. Treatment of murine coccidioidomycosis with polymyxin B.
    Antimicrob Agents Chemother. 1976 Aug;10(2):318-21 PMID: 185950
  14. Intravenous and intrathecal miconazole therapy for systemic mycoses.
    West J Med. 1977 Jan;126(1):5-13 PMID: 576177
  15. In vitro antifungal activity of clotrimazole (Bay b 5097).
    Infect Immun. 1971 Aug;4(2):143-8 PMID: 4949484
  16. Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B.
    Sabouraudia. 1974 Nov;12(3):329-40 PMID: 4610825
  17. Obfuscation of the activity of antifungal antimicrobics by culture media.
    J Infect Dis. 1972 Oct;126(4):353-61 PMID: 4561725
  18. Inhibition of growth of Coccidioides immitis on Sabouraud medium containing polymyxin B.
    J Clin Microbiol. 1975 Mar;1(3):335-6 PMID: 170311
  19. Inhibition of Coccidioides immitis in vitro and enhancement of antiococcidiodial effects of amphotericin B by polymyxin B.
    Antimicrob Agents Chemother. 1975 Jun;7(6):781-7 PMID: 168806
  20. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    J Infect Dis. 1975 Aug;132(2):133-41 PMID: 1099147
  21. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man.
    Am J Med. 1976 Feb;60(2):191-202 PMID: 766623
  22. Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.
    Antimicrob Agents Chemother. 1976 Mar;9(3):406-13 PMID: 1259400
  23. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro.
    J Infect Dis. 1975 Oct;132(4):407-14 PMID: 1185010
  24. Amphotericin B serum concentrations during therapy.
    Appl Microbiol. 1970 Jun;19(6):955-9 PMID: 5456013
  25. Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines.
    Trans N Y Acad Sci. 1960 Apr;22:436-49 PMID: 14416255
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1977-06-00
Pages
1049-55
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC352127
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com